Verition Fund Management LLC Takes Position in Nano-X Imaging Ltd. (NASDAQ:NNOX)

Verition Fund Management LLC acquired a new stake in Nano-X Imaging Ltd. (NASDAQ:NNOX) in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 14,540 shares of the company’s stock, valued at approximately $88,000.

Several other large investors have also bought and sold shares of the company. Griffin Asset Management Inc. raised its position in Nano-X Imaging by 0.7% in the second quarter. Griffin Asset Management Inc. now owns 203,911 shares of the company’s stock worth $1,497,000 after acquiring an additional 1,500 shares in the last quarter. Tempus Wealth Planning LLC grew its stake in shares of Nano-X Imaging by 11.1% in the 2nd quarter. Tempus Wealth Planning LLC now owns 116,907 shares of the company’s stock worth $858,000 after purchasing an additional 11,692 shares during the last quarter. Bank of New York Mellon Corp raised its holdings in shares of Nano-X Imaging by 7.6% in the 2nd quarter. Bank of New York Mellon Corp now owns 185,167 shares of the company’s stock worth $1,359,000 after purchasing an additional 13,085 shares in the last quarter. Van ECK Associates Corp lifted its stake in Nano-X Imaging by 14.1% during the second quarter. Van ECK Associates Corp now owns 22,293 shares of the company’s stock valued at $164,000 after purchasing an additional 2,755 shares during the last quarter. Finally, Rhumbline Advisers lifted its stake in Nano-X Imaging by 3.9% during the second quarter. Rhumbline Advisers now owns 75,920 shares of the company’s stock valued at $557,000 after purchasing an additional 2,818 shares during the last quarter. Institutional investors own 21.49% of the company’s stock.

Nano-X Imaging Stock Down 0.7 %

Shares of Nano-X Imaging stock opened at $7.31 on Wednesday. Nano-X Imaging Ltd. has a 12-month low of $5.26 and a 12-month high of $14.28. The stock’s fifty day moving average is $6.31 and its 200-day moving average is $6.82.

Analyst Ratings Changes

Separately, Cantor Fitzgerald upped their price target on Nano-X Imaging from $11.00 to $12.00 and gave the company an “overweight” rating in a report on Friday, December 6th.

About Nano-X Imaging

Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. Its X-ray source is based on a digital micro-electro-mechanical systems semiconductor cathode.